Congo vs Gabon: Statin use vs. average non-HDL cholesterol levels
Congo
2.8
in 2018
Gabon
2.8
in 2018
Congo rank
163rd
Gabon rank
163rd
Statin use vs. average non-HDL cholesterol levels over time
- Congo
- Gabon
How they compare
Congo currently reports 2.8 against 2.8 in Gabon, a difference of 0.
Across all 39 years both countries report, Gabon has been ahead every year.
Congo ranks 163rd and Gabon ranks 163rd of 191 countries.
Gabon has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Congo | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.88 | 2.98 | 0.1 | Gabon |
| 1990s | 2.9 | 3.1 | 0.2 | Gabon |
| 2000s | 2.9 | 3 | 0.1 | Gabon |
| 2010s | 2.86 | 2.89 | 0.0333 | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Congo or Gabon?
- Congo, at 2.8 against 2.8 in Gabon as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Congo and Gabon?
- 0, with Congo ahead.
- How many years of comparable data are there for Congo and Gabon?
- 39 years are reported by both, from 1980 to 2018.
- How do Congo and Gabon rank globally for statin use vs. average non-hdl cholesterol levels?
- Congo ranks 163rd and Gabon ranks 163rd of 191 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.